JNJ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
This is the expense the company spent on research and development. Johnson & Johnson's research and development for the three months ended in Mar. 2016 was $2,013 Mil. Its research and development for the trailing twelve months (TTM) ended in Mar. 2016 was $9,160 Mil.
This is the expense the company spent on research and development.
Johnson & Johnson Research & Development for the trailing twelve months (TTM) ended in Mar. 2016 was 2129 (Jun. 2015 ) + 2154 (Sep. 2015 ) + 2864 (Dec. 2015 ) + 2013 (Mar. 2016 ) = $9,160 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
If competitive advantage is created by a patent or tech advantage, at some point it will disappear.
High R&D usually dictates high SG&A which threatens the competitive advantage.
Johnson & Johnson Annual Data
|Research & Development||7,125||7,680||7,577||6,986||6,844||7,548||7,665||8,183||8,672||9,046|
Johnson & Johnson Quarterly Data
|Research & Development||2,169||1,831||2,005||2,023||2,635||1,899||2,129||2,154||2,864||2,013|